U.S. Markets closed

Global Ear Infection Treatment Market 2019-2023 | Evolving Opportunities with GlaxoSmithKline and Johnson & Johnson | Technavio

Technavio has been monitoring the global ear infection treatment market since 2018 and the market is poised to grow by USD 2.79 billion during 2019-2023, progressing at a CAGR of more than 5% during the forecast period. Request free sample pages

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200106005647/en/

Technavio announced its latest market research report titled global ear infection treatment market 2019-2023. (Graphic: Business Wire)

Read the 114-page report with TOC on "Ear Infection Treatment Market Analysis Report by Type (Middle ear infections, Outer ear infections, and Inner ear infections), Geography (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2019-2023".


The market is driven by the high risk factors for ear infections. In addition, rising funds for research on ear infections is anticipated to boost the growth of the ear infection treatment market.

The prevalence of various ear infections such as AOE, OME, and AOM are increasing owing to the increase in risk factors such as bacteria, viral infections, ear injuries, and cigarette smoking. The use of external objects such as cotton swabs and hairpins causes bruises and cuts in the ear canal and increases the chances of developing acute otitis externa (AOE). Similarly, exposure to cigarette smoke increases the probability of causing acute otitis media (AOM). This increase in the incidence of ear infections is boosting the demand for ear infection treatments, thereby driving the market growth during the faorecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Ear Infection Treatment Market Companies:


GlaxoSmithKline operates the business across segments such as Pharmaceuticals, Vaccines, and Consumer healthcare. AMOXIL and NEOSPORIN H ear drops are the key products offered by the company.

Johnson & Johnson

Johnson & Johnson operates the business across segments such as Consumer, Pharmaceutical, and Medical devices. POLYSPORIN + Pain Relief Ear Drops is the key offering of the company.


Novartis operates the business across Innovative medicines, Sandoz, and Alcon segments. CIPRODEX is one of the key offerings of the company.


Otonomy operates the business through the Pharmaceuticals segment. OTIPRIO is one of the company’s key offerings. It is a sterile, preservative-free, otic suspension of 6% ciprofloxacin administered as a single-dose.


Pfizer operates the business across segments such as Innovative health and Essential health. ZITHROMAX is one of the key offerings of the company. It contains the active ingredient azithromycin, a subclass of macrolide antibiotics, for oral administration.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Technavio has segmented the ear infection treatment market based on the type and region.

Ear Infection Treatment Type Outlook (Revenue, USD Billion, 2019 - 2023)

  • Middle ear infections
  • Outer ear infections
  • Inner ear infections

Ear Infection Treatment Regional Outlook (Revenue, USD Billion, 2019 - 2023)

  • Asia
  • Europe
  • North America
  • ROW

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Healthcare include:

Global Ear Tube Devices Market – Global ear tube devices market by material (fluoroplastic tube, silicon tube, metal tube, and others), end-users (hospitals, ASCs, and others), and geography (Asia, Europe, North America, and ROW).

Global Middle Ear Implants Market – Global middle ear implants market by product (electromagnetic middle ear implants and piezoelectric middle ear implants), application (sensorineural hearing loss, conductive hearing loss, and mixed hearing loss), and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20200106005647/en/


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200